Clinical Research Considerations for Cystic Fibrosis Studies
Presented by Dr Silke van Koningsbruggen-Rietschel, Pediatric Pulmonologist and Head of the CF Clinical Research Center at the CF Centre Cologne, University Hospital of Cologne, Germany.
Topics covered
- Cystic Fibrosis in general: where are we?
- The changing landscape with CFTR-modulators
- Drug development in Cystic Fibrosis
- Pulmonary function testing and other outcome parameters in clinical trials
- Organoids as biomarkers
- The role of home spirometry in clinical trials
- European CF Society Clinical Trial Network (ECFS-CTN)
Presented By
Dr Silke van Koningsbruggen-Rietschel
About the Presenter
Dr Silke van Koningsbruggen-Rietschel is a Pediatric Pulmonologist and Head of the Cystic Fibrosis Clinical Research Center at the Cystic Fibrosis Centre Cologne, University Hospital of Cologne, Germany. She has been a specialist in Pediatric Pulmonology, Allergology and CF since 1995 and has been principal or lead principal investigator in numerous industry-sponsored clinical trials as well as investigator-initiated trials in the field of CF for more than 25 years.News & Insights
Related Content
Related Exhale Podcasts
Related Webinars
Resources
Related Resources
Related Reference Papers
